Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2020
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionKatharina Wöran, Georg Semmler, Mathias Jachs, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2026
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLDLorenz Balcar, Georg Semmler, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2024
The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled studyDavid J M Bauer, Larissa Nixdorf, Nina Dominik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2025
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative StudyChristian Sebesta, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Ida Falk Villesen, Georg Semmler, et al.
Hepatology International|May 22, 2021
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomesLukas Hartl, Mathias Jachs, Christopher Desbalmes, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case seriesChristopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Gastroenterology|July 13, 2023
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver DiseaseGeorg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2020
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionKatharina Wöran, Georg Semmler, Mathias Jachs, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2026
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLDLorenz Balcar, Georg Semmler, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2024
The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled studyDavid J M Bauer, Larissa Nixdorf, Nina Dominik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2025
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative StudyChristian Sebesta, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Ida Falk Villesen, Georg Semmler, et al.
Hepatology International|May 22, 2021
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomesLukas Hartl, Mathias Jachs, Christopher Desbalmes, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case seriesChristopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Gastroenterology|July 13, 2023
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver DiseaseGeorg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Pageof 12